CVS Health Corporation (NYSE:CVS) Shares Purchased by Cullinan Associates Inc.

Cullinan Associates Inc. lifted its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 12.2% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 44,459 shares of the pharmacy operator's stock after purchasing an additional 4,841 shares during the quarter. Cullinan Associates Inc.'s holdings in CVS Health were worth $3,012,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the company. Center For Asset Management LLC purchased a new stake in shares of CVS Health during the 1st quarter worth about $219,000. Connective Portfolio Management LLC purchased a new stake in shares of CVS Health during the 1st quarter worth about $813,000. Praxis Investment Management Inc. boosted its holdings in CVS Health by 32.3% in the 1st quarter. Praxis Investment Management Inc. now owns 34,194 shares of the pharmacy operator's stock worth $2,317,000 after acquiring an additional 8,340 shares during the period. Stonegate Investment Group LLC boosted its holdings in CVS Health by 103.3% in the 1st quarter. Stonegate Investment Group LLC now owns 18,495 shares of the pharmacy operator's stock worth $1,253,000 after acquiring an additional 9,399 shares during the period. Finally, Petra Financial Advisors Inc. purchased a new position in CVS Health in the 1st quarter worth approximately $295,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

Shares of CVS stock traded down $0.15 on Friday, hitting $66.69. 11,828,346 shares of the stock traded hands, compared to its average volume of 10,923,499. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.82 and a quick ratio of 0.63. The company has a market capitalization of $84.36 billion, a PE ratio of 15.92, a PEG ratio of 0.95 and a beta of 0.56. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $72.51. The company's fifty day moving average is $64.92 and its 200 day moving average is $60.45.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The business's revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.31 EPS. On average, equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CVS shares. Barclays set a $79.00 price target on CVS Health and gave the stock an "overweight" rating in a report on Monday, June 2nd. Wells Fargo & Company restated an "overweight" rating and issued a $84.00 price target (up previously from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Royal Bank Of Canada upped their price target on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Two research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $74.75.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone purchased 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director now owns 12,007 shares in the company, valued at approximately $764,845.90. The trade was a 15.04% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.22% of the company's stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.